Search hospitals > Louisiana > Baton Rouge

Louisiana Hematology Oncology Associates LLC

Claim this profile
Baton Rouge, Louisiana 70809
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Breast cancer
Conducts research for Cancer
Conducts research for Colorectal Cancer
88 reported clinical trials
4 medical researchers
Photo of Louisiana Hematology Oncology Associates LLC in Baton RougePhoto of Louisiana Hematology Oncology Associates LLC in Baton RougePhoto of Louisiana Hematology Oncology Associates LLC in Baton Rouge

Summary

Louisiana Hematology Oncology Associates LLC is a medical facility located in Baton Rouge, Louisiana. This center is recognized for care of Lung Cancer, Breast Cancer, Breast cancer, Cancer, Colorectal Cancer and other specialties. Louisiana Hematology Oncology Associates LLC is involved with conducting 88 clinical trials across 135 conditions. There are 4 research doctors associated with this hospital, such as David S. Hanson, Victor T. Lin, Augusto C. Ochoa, and William T. Varnado.

Area of expertise

1Lung Cancer
Global Leader
Louisiana Hematology Oncology Associates LLC has run 25 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage II
Stage I
2Breast Cancer
Global Leader
Louisiana Hematology Oncology Associates LLC has run 19 trials for Breast Cancer. Some of their research focus areas include:
HER2 negative
ER positive
Stage IV

Top PIs

Clinical Trials running at Louisiana Hematology Oncology Associates LLC

Bladder Cancer
Lung Cancer
Breast Cancer
Breast cancer
Cancer
Pancreatic Cancer
Prostate Cancer
Colorectal Cancer
Pancreatic Carcinoma
Kidney Cancer
Image of trial facility.

Eribulin + Chemotherapy

for Bladder Cancer

This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting2 awards Phase 3
Image of trial facility.

Gemcitabine + Cisplatin

for Bladder Cancer

This phase II trial studies how well gemcitabine hydrochloride and cisplatin work in treating participants with invasive bladder urothelial cancer. Drugs used in chemotherapy, such as gemcitabine hydrochloride and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.
Recruiting1 award Phase 2
Image of trial facility.

Blood Sample Collection

for Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.
Recruiting1 award N/A9 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Louisiana Hematology Oncology Associates LLC?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security